Macrocyclic peptides
US9090671B2 · kind B2 · utility
0Cited by
29References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 5, 2009 |
| Grant date | Jul 28, 2015 |
| Priority date | — |
| Expiry date | Oct 17, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are cyclosporine derivatives in which the 3-Sarcosine carbon and 5-Valine nitrogen are each substituted by a non-hydrogen substituent, and their use as pharmaceuticals, in particular for the treatment of hepatitis C virus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.